ATE435019T1 - Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung - Google Patents

Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung

Info

Publication number
ATE435019T1
ATE435019T1 AT01967534T AT01967534T ATE435019T1 AT E435019 T1 ATE435019 T1 AT E435019T1 AT 01967534 T AT01967534 T AT 01967534T AT 01967534 T AT01967534 T AT 01967534T AT E435019 T1 ATE435019 T1 AT E435019T1
Authority
AT
Austria
Prior art keywords
diuretic
sulfonyl urea
antiviral treatment
treatment
antiviral
Prior art date
Application number
AT01967534T
Other languages
English (en)
Inventor
Ian Stuart Pardoe
Christopher Edward Hartley
Original Assignee
Henderson Morley Res & Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0023199A external-priority patent/GB2367242B/en
Priority claimed from GB0104030A external-priority patent/GB0104030D0/en
Priority claimed from GB0104031A external-priority patent/GB0104031D0/en
Priority claimed from GB0114947A external-priority patent/GB2376628B/en
Application filed by Henderson Morley Res & Dev Ltd filed Critical Henderson Morley Res & Dev Ltd
Application granted granted Critical
Publication of ATE435019T1 publication Critical patent/ATE435019T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01967534T 2000-09-21 2001-09-21 Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung ATE435019T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0023199A GB2367242B (en) 2000-09-21 2000-09-21 Antiviral treatment
GB0104030A GB0104030D0 (en) 2001-02-19 2001-02-19 Antiviral treatment
GB0104031A GB0104031D0 (en) 2001-02-19 2001-02-19 Antiviral treatment
GB0114947A GB2376628B (en) 2001-06-19 2001-06-19 Treatment of DNA viral infections in cats
PCT/GB2001/004206 WO2002024207A1 (en) 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment

Publications (1)

Publication Number Publication Date
ATE435019T1 true ATE435019T1 (de) 2009-07-15

Family

ID=27447886

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01967534T ATE435019T1 (de) 2000-09-21 2001-09-21 Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung

Country Status (6)

Country Link
US (1) US20040034016A1 (de)
EP (1) EP1322316B1 (de)
AT (1) ATE435019T1 (de)
AU (1) AU2001287907A1 (de)
DE (1) DE60139134D1 (de)
WO (1) WO2002024207A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1242096B1 (de) * 1999-12-30 2005-10-12 Henderson Morley Research and Development Limited Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten
DE602004029651D1 (de) 2003-02-12 2010-12-02 Univ Georgetown Verwendung von artemisinin zur behandlung von durch onkogene viren gebildeten tumoren und zur behandlung von viralen infektionen
US20070238740A1 (en) 2003-08-28 2007-10-11 Nitromed, Inc. Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use
AU2006216665A1 (en) 2005-02-24 2006-08-31 Nicox S.A. Nitric oxide enhancing diuretic compounds, compositions and methods of use
GB0517840D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Topical anti viral formulations
GB0517838D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Transdermal active principle delivery means
WO2014164730A2 (en) 2013-03-12 2014-10-09 The Board Of Trustees Of The Leland Stanford Junior University Modulation of cellular dna repair activity to intercept malignancy
US10624923B2 (en) 2014-03-26 2020-04-21 Enrique G. Gutierrez Compositions and related methods for treating and preventing viral and retroviral infections
US11260074B2 (en) 2014-03-26 2022-03-01 Enrique G. Gutierrez Compositions and related methods for reconstituting the immune system of a subject

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
JPH07179347A (ja) * 1993-12-21 1995-07-18 Showa Shell Sekiyu Kk 抗ウイルス組成物
US5686100A (en) * 1994-11-22 1997-11-11 E.R. Squibb & Sons, Inc. Prophylactic and therapeutic treatment of skin sensitization and irritation
FR2770925B1 (fr) * 1997-11-12 2000-01-07 Sagem Procede de transmission de telecommandes
CA2395016C (en) * 1999-12-30 2009-04-14 Henderson Morley Research And Development Limited Treatment of dna viral infections
EP1242096B1 (de) * 1999-12-30 2005-10-12 Henderson Morley Research and Development Limited Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten

Also Published As

Publication number Publication date
EP1322316B1 (de) 2009-07-01
WO2002024207A1 (en) 2002-03-28
DE60139134D1 (de) 2009-08-13
AU2001287907A1 (en) 2002-04-02
EP1322316A1 (de) 2003-07-02
US20040034016A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
ME01222B (me) Nova kombinovana upotreba jedinjenja sulfonamida u liječenju kancera
BR0107403A (pt) Compostos de n-(5,7-dimetóxi[1,2,4] triazolo[1,5-alfa]pirimidin-2-il)arilsulfonamida e o uso dos mesmos como herbicidas
FI955315A0 (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
ATE245641T1 (de) Antivirale pyrimidinderivate
IS7556A (is) Uppsöfnun í frumu á phosphomate hliðstæðum a HIV próteasa hindrandi efnasamböndum
DE60317060D1 (de) Mikrobizide pyrimidine oder triazine zur vorbeugung der sexuellen übertragung von hiv
FI906212A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDSin hoidossa
DE60029186D1 (de) Keramischer Schaumkörper
DK0634927T3 (da) Behandling og profylakse af sygdomme forårsaget af parasitter eller bakterier
DE60219292D1 (de) Pyrazolderivate zur behandlung von hiv
DE60311272D1 (de) Neue purin- oder pyrrolol(2,3-d)pyrimidin-2-carbonsäurenitrile zur behandlung von mit cysteinproteaseaktivität assoziierten krankheiten
ATE418554T1 (de) 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
BR0105648B1 (pt) artigo descartÁvel do vestuÁrio.
ATE249219T1 (de) Antivirale verbindungen
DE60020820D1 (de) Thiadiazolyl-harnstoffe oder -thioharnstoffe zur antiviralen behandlung
DE60100625D1 (de) Verwndung von verbindungen mit 5-ht1a aktivität zur behandlung von krankheiten der äusseren retina
DK1362052T3 (da) Inhibitorer af cruzipain og andre cysteinproteaser
DK1299354T3 (da) Faktor VIIA hæmmende (thio)urea-derivater, fremstilling og anvendelse deraf
FI923158A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoidossa
DE69928779D1 (de) Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion
ATE435019T1 (de) Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung
DK1242119T3 (da) Kombinationer til behandling af DNA-virale infektioner omfattende et loop-diuretikum og et hjerteglycosid
DE60015568D1 (de) Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties